THE SAFETY OF LIPOSOMAL CYTARABINE IN CENTRAL NERVOUS SYSTEM INFILTRATION BY HAEMATOLOGIC MALIGNANCIES

EHA Library, Patricia García Ramírez, 182443

RETROSPECTIVE ANALYSIS OF OUTCOMES FOR ELDERLY PATIENTS WITH STAGE 3 AND 4 DISEASE HIGH-GRADE DLBCL WITH REDUCED CYCLES OF R-CHOP OR R-GCVP : A 7 YEARS SINGLE-INSTITUTE EXPERIENCE.

EHA Library, Mahesh Prahladan, 182444

MULTIPLE NEOPLASMS CONSIST OF SOLID CANCER AND NON-HODGKIN LYMPHOMA

EHA Library, K Natori, 182445

RETROSPECTIVE EVALUATION ON EFFICACY AND FEASIBILITY OF R-CODOX-M/IVAC REGIMEN IN AGGRESSIVE DLBCL

EHA Library, Elisa Coviello, 182446

OLDER PATIENTS WITH DLCLB- BODY MASS INDEX AS A PREDICTOR OF SURVIVAL

EHA Library, Mila Purić, 182447

STOMACH DIFFUSE LARGE B-CELL LYMPHOMA: A SINGLE CENTER EXPERIENCE

EHA Library, Meng-Ta Sung, 182448

IMMUNOHISTOCHEMISTRY BIOMARKERS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE STUDY

EHA Library, Paula Cristina Gaspar Brandao de Sousa e Sant, 182449

INVESTIGATION ON TREATMENT STRATEGY, PROGNOSTIC FACTORS, AND RISK FACTORS FOR EARLY DEATH IN ELDERLY TAIWANESE PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, SHIH-FENG CHO, 182450

TREATMENT OUTCOME OF MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA (MEITL): EXPERIENCE FROM AN ASIAN CANCER CENTER

EHA Library, Meng-Ta Sung, 182451

OSTEOPONTIN AS PRONOSTIC FACTOR OF DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Gilberto Israel Barranco Lampón, 182452

TREATMENT OF NEWLY DIAGNOSED CENTRAL NERVOUS SYSTEM (CNS) LYMPHOMA PATIENTS BASED ON COMORBIDITIES & PERFORMANCE STATUS: A SINGLE-CENTRE EXPERIENCE.

EHA Library, Yeong Jer Lim, 182453

AN AUDIT OF THE USE OF RASBURICASE FOR THE PREVENTION AND TREATMENT OF TUMOUR LYSIS SYNDROME IN PATIENTS RECEIVING TREATMENT AT THE NORTHERN CENTRE FOR CANCER CARE, NEWCASTLE UPON TYNE, UK.

EHA Library, Emily Watts, 182454

IMPLICATION OF BASIC VALUES OF VITAMIN D IN THE CLINICAL COMPLICATIONS OF PATIENTS WITH NO HODGKIN LYMPHOMA IN ACTIVE CHEMOTHERAPY TREATMENT

EHA Library, Rafael Martos Martinez, 182455

PROGNOSTIC IMPACT OF SYNCHRONOUS MULTIPLE PRIMARY MALIGNANT TUMORS ON NEWLY DIAGNOSED LYMPHOMA PATIENTS

EHA Library, Satoshi Nishiwaki, 182456

GLOBAL HEMOSTATIC ASSAY AT DIFFERENT TARGET ACTIVITY OF FACTOR VIII AND FACTOR IX

EHA Library, Kiyoung Yoo, 182457

THE RATE OF SUCCESSFUL IMMUNOTOLERANCE INDUCTION IN HAEMOPHILIA A BOYS TREATED WITH OCTOCOG ALFA - THE EXPERIENCE OF POLISH PAEDIATRIC HAEMOPHILIA CARE CENTRES

EHA Library, Andrzej Koltan, 182458

APPROACH TO PREGNANCY IN NIEMANN PICK DISEASE TYPE B PATIENT

EHA Library, Danijela Agić, 182459

SINGLE CENTRE FX DEFICIENCY EXPERIENCE

EHA Library, ZAFER BASLAR, 182460

IMPROVEMENT OF THE SURVIVAL FOR LIFE-THREATENING HEMORRHAGE WITH HEMOPHILIA PATIENT

EHA Library, Kun Soo Lee, 182461

CAN BLEEDING SCORE AND FACTOR LEVELS DETERMINE HEMOPHILIA CARRIERS?

EHA Library, Yilmaz Ay, 182462

FETAL INTRACRANIAL HEMORRHAGE AS A PRESENTING FEATURE OF SEVERE CONGENITAL FACTOR VII DEFICIENCY: THE NEED FOR EARLY PROPHYLAXIS

EHA Library, Mohamed Elshinawy, 182463

THE ASSOCIATION OF BLOOD TYPE WITH THE NEED FOR TRANSFUSIONS IN PATIENTS WITH VENTRICULAR ASSIST DEVICES

EHA Library, Theoni Kanellopoulou, 182464

ACQUIRED PURE RED CELL APLASIA ASSOCIATED WITH LYMPHOPROLIFERATIVE DISEASES IN ERYTHROPOIETIN-REFRACTORY ANEMIA PATIENTS ON DIALYSIS

EHA Library, Kentaro Yoshinaga, 182465

ADULT PATIENTS WITH ACQUIRED PURE RED CELL APLASIA: TREATED BY CYCLOSPORINE A OR CORTICOSTEROIDS：SIMILAR EFFICIENCY

EHA Library, Guangsheng He, 182466

REACTIVATION OF HEPATITIS B VIRUS INFECTION IN APLASTIC ANEMIA PATIENTS

EHA Library, Guangsheng He, 182467

MULTICENTER RESULTS OF SCHWACHMAN-DIAMOND SYNDROME PATIENTS

EHA Library, Sule Unal, 182468

PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH ) AND APLASTIC ANAEMIA - DATA FROM THE SPANISH PNH REGISTRY.

EHA Library, Silvia de la iglesia, 182469

AUTOIMMUNE CYTOPENIAS IN PRIMARY IMMUNODEFICIENCY DISEASES: SINGLE CENTER EXPERIENCE

EHA Library, Turkan Patıroglu, 182470

HEAVY METAL LEVELS IN PATIENTS WITH FANCONI APLASTIC ANEMIA

EHA Library, Turan Bayhan, 182471

CLINICAL IMPACT OF AGE AND COMORBIDITY IN PNH PATIENTS

EHA Library, Enrique Colado varela, 182472

A RARE ASSOCIATION: EBSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER AND PURE RED CELL APLASIA

EHA Library, Selin Berk, 182473

LDH AS PREDICTIVE PARAMETER IN TREATMENT-NAÏVE PATIENTS WITH TRISOMY 12 CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Francesco Autore, 182474

THE PERCENTAGE OF CELLS WITH ABNORMALITIES IN FISH STUDIES CONFERS PROGNOSTIC INFORMATION IN CLL PATIENTS

EHA Library, Isabel González-Gascón y Marín, 182475

METHYLATION STATUS OF RAD21 GENE IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Kalliopi Manola, 182476

ROLE OF KEAP1-NRF2 PATHWAY GENETIC VARIABILITY IN THE SUSCEPTIBILITY AND PROGNOSIS OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, José Carda, 182477

EVALUATION OF BASAL CHROMOSOME ABERRATIONS AND MICRONUCLEUS FREQUENCY IN UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND THEIR ASSOCIATION WITH PROGNOSTIC MARKERS

EHA Library, Micaela Palmitelli, 182478

B CELLS RESISTANT TO CD20 MONOCLONAL ANTIBODIES DISPLAY SPECIFIC ALTERATIONS IN GENE EXPRESSION PROFILE

EHA Library, Aneta Ledererova, 182479

DIFFERENTIAL EXPRESSION PATTERNS OF CHEMOKINE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Eva Kriegová, 182480

RESIDUAL SERUM CONCENTRATIONS OF RITUXIMAB ARE ASSOCIATED WITH RELAPSE RISK IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Adrian Tempescul, 182481

ACTIVITY OF THE CD19 ANTIBODY MOR208 IN COMBINATION WITH IBRUTINIB, IDELALISIB OR VENETOCLAX IN VITRO

EHA Library, Rainer Boxhammer, 182482

LYMPHOCYTE EXHAUSTION AND THE NATURAL HISTORY OF CHRONIC LYMPHOCYTIC LEUKEMIA - FRIENDS OR FOES?

EHA Library, Ewelina Grywalska, 182483

HSP70 AND HSF1 GO HAND IN HAND AND HAVE A ROLE IN THE SURVIVAL OF CHRONIC LYMPHOCYTIC LEUKEMIA NEOPLASTIC B CELLS.

EHA Library, Livio Trentin, 182484

OVEREXPRESSION OF GENE FOR HUMAN CONCENTRATIVE NUCLEOSIDE TRANSPORTER 3 IS A PREDICTOR OF RESISTANCE TO FLUDARABIN-BASED CHEMOTHERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Vojin Vukovic, 182485

THE SPECTRUM OF TP53, SF3B1, AND NOTCH1 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS EXPOSED TO IONIZING RADIATION DUE TO THE CHORNOBYL NPP ACCIDENT

EHA Library, Nadiia Bilous, 182486

DRUG SENSITIVITY SCREENING IN CHRONIC LYMPHATIC LEUKEMIA (CLL) AND MULTIPLE MYELOMA (MM) FOR PERSONALIZED CANCER THERAPY.

EHA Library, Deepak balaji Thimiri Govinda Raj, 182487

FCGR2A AND FCGR3A VARIANTS ARE NOT ASSOCIATED WITH RESPONSE TO RITUXIMAB IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Marica Pavkovic, 182488

MUTATIONAL STATUS, IMMUNOGLOBULIN HEAVY VARIABLE (IGHV) GENES PATTERN AND STEREOTYPED RECEPTORS REPERTOIRE OF MACEDONIAN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS

EHA Library, Irina Panovska, 182489

LAMBDA LIGHT CHAIN RESTRICTION - USEFUL FOR HAIRY CELL LEUKEMIA PROGNOSTICATION?

EHA Library, Joana LIMA ARAUJO, 182490

CLINICAL EFFICACY AND LONG-TERM OUTCOMES OF SPLENECTOMY IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Maksym Semerak, 182491

MONOCLONAL B-CELL LYMPHOCYTOSIS IN THAI POPULATION: PREVALENCE AND IMMONOPHENOTYPIC CHARACTERISTICS

EHA Library, Piyanuch Kongtim, 182492

SPONTANEOUS CLINICAL REGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA: CLINICAL AND BIOLOGIC FEATURES OF 9 CASES FROM THE ERIC REGISTRY

EHA Library, Ilaria Del Giudice, 182493

CLINICAL AND LABORATORY CHARACTERIZATION OF PLATELET DYSFUNCTION DURING IBRUTINIB TREATMENT IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. MONOCENTRIC EXPERIENCE.

EHA Library, Idanna Innocenti, 182494

HAIRY CELL LEUKEMIA :A SUMMARY OF CLINICAL DATA ON 202 PATIENTS AND THE RESULTS OF THERAPY WITH CLADRIBINE IN ISRAEL

EHA Library, Tamar Tadmor, 182495

CHRONIC LYMPHOCYTIC LEUKEMIA: CHANGES IN CLINICAL STAGE DISCRIMINATE PATIENTS WITH DIFFERENT OUTCOME WITHIN THE IWCLL PARTIAL RESPONSE CATEGORY.

EHA Library, Eva Puy Vicente, 182496

INCIDENCE OF THYROID GLAND DISORDERS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, ANIL TOMBAK, 182497

CLINICAL-BIOLOGICAL CHARACTERISTICS, TREATMENT OUTCOME AND SURVIVAL OF SMALL LYMPHOCYTIC LYMPHOMA (SLL) PATIENTS: A REAL-LIFE EXPERIENCE

EHA Library, Sotirios Sachanas, 182498

HEMINSIGHT TO ASSESS PATIENT REPORTED OUTCOMES OF PATIENTS AFFECTED BY CHRONIC LYMPHOCYTIC LEUKEMIA IN DAILY CLINICAL PRACTICE

EHA Library, Bruno Fattizzo, 182499

HEALTHCARE COST OF MEDICARE PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Carolina Reyes, 182500

THE ROLE OF MAINTENANCE THERAPY IN THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Aleksei Kuvshinov, 182501

MULTISITE PERFORMANCE EVALUATION STUDY OF THE BD ONEFLOW LYMPHOID SCREENING TUBE (LST)

EHA Library, Balaji Balasa, 182502

IMMUNOGLOBULIN HEAVY/LIGHT CHAIN ASSAY DETECT IMMUNE DYSREGULATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Tamar Tadmor, 182503

INFLUENCE OF TREATMENT ON CONCENTRATION OF CYTOKINES IN BLOOD OF PATIENTS WITH HAIRY CELL LEUKEMIA

EHA Library, Nataliya Pelenyo, 182504

PROGRESSION-FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) - CLINICAL BENEFITS OF ACHIEVING A DEEP RESPONSE TO FIRST-LINE THERAPY

EHA Library, Jennifer Samp, 182505

ANTI-CD ANTIBODY MICROARRAY FOR MORPHOLOGY EXAMINATION OF CIRCULATING LEUKEMIA AND LYMPHOMA CELLS

EHA Library, Sofya Kuznetsova, 182506

COMPARATIVE ANALYSIS OF INTERNATIONAL PROGNOSTIC INDEX FOR CHRONIC LYMPHOCYTIC LEUKEMIA, PROGRESSION-RISK SCORE AND MD ANDERSON CANCER CENTER 2011 SCORE: REAL WORLD DATA FROM A SINGLE INSTITUTION

EHA Library, Vojin Vukovic, 182507

MULTISITE PERFORMANCE EVALUATION STUDY OF THE BD ONEFLOW B-CELL CHRONIC LYMPHOPROLIFERATIVE DISORDERS T1 (B-CLPD T1) PANEL

EHA Library, Balaji Balasa, 182508

COMBINED PATTERNS OF IGHV REPERTOIRE AND MOLECULAR ALTERATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA- SINGLE CENTER EXPERIENCE

EHA Library, S.T. Trajkova, 182509

PROGNOSTIC SIGNIFICANCE OF SERUM BAFF, APRIL, TACI AND BCMA LEVELS IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Ilay Berke mentese, 182510

EXPERIENCE OF IBRUTINIB IN RELAPSED/REFRACTORY B-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA AND MANTLE CELL LYMPHOMA IN A U.K. DISTRICT GENERAL HOSPITAL

EHA Library, adrian smith, 182511

THE VALUE OF RITUXIMAB ADDITION TO CHEMOTHERAPY TREATMENT OF REAL-WORLD CLL PATIENTS: A 15 YEAR SINGLE CENTER EXPERIENCE

EHA Library, Lina Van Der Straten, 182512

RICHTER SYNDROME: SERBIAN LYMPHOMA GROUP EXPERIENCE

EHA Library, Vojin Vukovic, 182513

INFECTIOUS COMPLICATIONS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA TREATED WITH IBRUTINIB

EHA Library, Ewa Wasik-Szczepaanek, 182514

MONOCLONAL B-CELL LYMPHOCYTOSIS (MBL) AND PROSTATE CANCER: AN UNEXPECTED, POSSIBLE ASSOCIATION

EHA Library, Fiorella D'auria, 182515

IDENTIFICATION OF NOVEL MUTATIONS IN CANCER-RELATED GENES IN HUMAN ERYTHROLEUKEMIA K562 CELL LINE BY NEXT-GENERATION SEQUENCING

EHA Library, Monika Pepek, 182516

INVESTIGATION OF POLYMORPHISMS RELATED TO MIR-608 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Ildar Minniakhmetov, 182517

TARGETED STRATEGY FOR ABL TYROSINE KINASE INHIBITOR RESISTANT PHILADELPHIA CHROMOSOME POSITIVE LEUKEMIA CELLS

EHA Library, Seiichi Okabe, 182518

FLUORESCENCE IN SITU HYBRIDIZATION SIGNAL PATTERNS AND INTRACHROMOSOMAL BCR-ABL1 AMPLIFICATION ANALYSIS IN IMATINIB-RESISTANT CHRONIC MYELOGENOUS LEUKEMIA PATIENTS USING TRICOLOR DUAL FUSION PROBE.

EHA Library, Karthik Bommannan, 182519

ARE YOU ACTUALLY SUSPECTING A CHRONIC MYELOID LEUKEMIA WHEN ORDERING A BCR/ABL RT-PCR?

EHA Library, Carolina Guilen Rienda, 182520

BCR-ABL DEL. C.1086-1270 (P.R362FS*21) AND TKI RESISTANCE IN CML PATIENTS FROM RUSSIAN FEDERATION

EHA Library, Adhamjon Abdullaev, 182521

PEROXIREDOXIN II ACTIVITY HAS IMPORTANT ROLES TO CONTROL ABL TYROSINE KINASE ACTIVITY IN STIS TREATED CML PATIENTS AND ITS POTENTIAL APPLICATION IN IMATINIB RESISTANCE

EHA Library, Eun Sun Yoo, 182522

FUNCTIONAL CHARACTERISTICS OF ERYTHROID PROGENITOR CELLS OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB AND NILOTINIB

EHA Library, Tetiana Perekhrestenko, 182523

DEVELOPMENT OF FRAGMENT ANALYSIS MULTIPLEX-PCR METHOD TO DETECT TRANSCRIPTS OF BCR-ABL FUSION GENE IN CHRONIC MYELOID LEUKEMIA

EHA Library, Laura Reguilón Gallego, 182524

PDGF AND BDNF PLASMA LEVELS IN CML PATIENTS BEFORE AND AFTER INITIATION OF TKI THERAPY

EHA Library, Zofia Ulańczyk, 182526

A CASE OF ATYPICAL CHRONIC MYELOID LEUKEMIA WITH LATE DISCOVERY OF JAK2

EHA Library, Liliana Vila, 182527

E14A2 TRANSCRIPT IS ASSOCIATED WITH HIGHER PROBABILITY OF DURABLE TREATMENT FREE REMISSION IN CML PATIENTS

EHA Library, Mariella d adda, 182528

COMPARATIVE ANALYSES OF NILOTINIB VS HIGH-DOSE IMATIB VS SUSTAINING STANDARD-DOSE IMATINIB IN PATIENTS WITH CP CHRONIC MYELOID LEUKEMIA FOLLOWING SUBOPTIMAL MOLECULAR RESPONSE TO FIRST-LINE IMATINIB

EHA Library, Sung-Eun Lee, 182529

COMPARATIVE ANALYSIS OF PULMONARY HYPERTENSION IN THE 105 CML PATIENTS TREATED WITH IMATINIB, NILOTINIB AND DASATINIB

EHA Library, Mariko Minami, 182530

DYNAMICS OF BCR-ABL1 MUTATION ACQUISITION AND LONG-TIME MUTATION ASSOCIATED RESISTANCE PROGNOSIS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED BY TYROSINE KINASE INHIBITORS: RUSSIA, 2006-2016

EHA Library, Vera Tikhonova, 182531

IMPACT OF BCR-ABL1 TRANSCRIPT TYPE IN CHRONIC MYELOID LEUKEMIA TREATED FRONTLINE WITH NILOTINIB

EHA Library, Fausto Castagnetti, 182532

IMATINIB (IM) 400MG IN PATIENTS WITH CML1ST CP RESULTS IN A HIGHER MOLECULAR RESPONSE RATE AT 6 MONTHS COMPARED TO IM/ HYDROXYUREA. FINAL RESULTS OF THE CML2004 STUDY. NCT 02480608.

EHA Library, Thoralf Lange, 182533

A MULTICENTER, OBSERVATIONAL, AMBISPECTIVE STUDY EVALUATING EFFICACY AND SAFETY OF GENERIC IMATINIB COMPARED TO GLEEVEC IN CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE - 3 MONTHS RESPONSE ANALYSIS

EHA Library, Katia Pagnano, 182534

COMPLEX ADDITIONAL CHROMOSOME ABERRATIONS IN PH-POSITIVE CELLS IMPACT ON CHRONIC MYELOID LEUKEMIA PATIENTS’ SURVIVAL IN THE ERA OF TYROSINE KINASE INHIBITORS

EHA Library, Aleksandr Fomin, 182535

BCR/ABL1 TRANSCRIPT E13A2 IS ASSOCIATED WITH HIGHER CUMULATIVE PROBABILITY OF LOSS OF MAJOR MOLECULAR RESPONSE IN CML PATIENTS TREATED WITH NILOTINIB AS THE 2-ND LINE THERAPY

EHA Library, Iryna Dmytrenko, 182536

ANALYSIS OF GENERIC IMATINIB EFFICACY IN CHRONIC MYELOID LEUKEMIA TREATMENT: MORE THAN FOUR YEARS OF EXPERIENCE IN SOUTHERN SERBIA

EHA Library, Irena Cojbasic, 182537

ACHIEVING OPTIMAL RESPONSE AT 12 MONTHS IS ASSOCIATED WITH A BETTER HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: A PROSPECTIVE, LONGITUDINAL, SINGLE CENTER STUDY

EHA Library, Jiang Qian, 182538

MULTI-COUNTRY RETROSPECTIVE CHART AUDIT STUDY TO EXAMINE DEEP MOLECULAR RESPONSE (MR4.5) ASSOCIATED WITH SECOND-LINE TYROSINE KINASE INHIBITORS IN CHRONIC PHASE - CHRONIC MYELOGENOUS LEUKEMIA (CML-CP)

EHA Library, Jorge Cortes, 182539

COMPUTATIONALLY INTELLIGENT PREDICTION OF CLINICAL OUTCOME IN CHRONIC MYELOID LEUKEMIA

EHA Library, Irena Cojbasic, 182540

A NATIONWIDE OBSERVATIONAL STUDY OF PONATINIB IN CHRONIC MYELOCYTIC LEUKEMIA OUTSIDE CLINICAL TRIALS.

EHA Library, Adi Abulafia, 182541

MOLECULAR RESPONSE TO THERAPY WITH TYROSINE KINASE INHIBITORS IN PATIENTS WITH BCR-ABL1(+) CHRONIC MYELOID LEUKEMIA PRESENTING WITH AN ISOLATED THROMBOCYTOSIS AT THE ONSET

EHA Library, Gueorgui Balatzenko, 182542

BCR-ABL1 MOLECULAR RESPONSES AT 12-18 MONTHS USING THE QUANTIDEX QPCR BCR-ABL1 IS KIT PREDICT LONG-TERM EVENT-FREE SURVIVAL IN PATIENTS WITH TKI-TREATED CML

EHA Library, Justin Brown, 182543